Shared and Specific Lung Microbiota with Metabolic Profiles in Bronchoalveolar Lavage Fluid Between Infectious and Inflammatory Respiratory Diseases
Yukun He,Wenyi Yu,Pu Ning,Qiongzhen Luo,Lili Zhao,Yu Xie,Yan Yu,Xinqian Ma,Li Chen,Yali Zheng,Zhancheng Gao
DOI: https://doi.org/10.2147/JIR.S342462
IF: 4.5
2022-01-11
Journal of Inflammation Research
Abstract:Yukun He, 1 Wenyi Yu, 1 Pu Ning, 1, 2 Qiongzhen Luo, 1, 3 Lili Zhao, 1 Yu Xie, 1 Yan Yu, 1 Xinqian Ma, 1 Li Chen, 1 Yali Zheng, 1, 4 Zhancheng Gao 1, 4 1 Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China; 3 Department of Respiratory & Critical Care Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, People's Republic of China; 4 Department of Respiratory, Critical Care, and Sleep Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China Correspondence: Yali Zheng Department of Respiratory, Critical Care, and Sleep Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China Email Zhancheng Gao Department of Pulmonary and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, People's Republic of China Email Background: Infiltration of the lower respiratory tract (LRT) microenvironment could be significantly associated with respiratory diseases. However, alterations in the LRT microbiome and metabolome in infectious and inflammatory respiratory diseases and their correlation with inflammation still need to be explored. Methods: Bronchoalveolar lavage samples from 44 community-acquired pneumonia (CAP) patients, 29 connective tissue disease-associated interstitial disease (CTD-ILD) patients, and 30 healthy volunteers were used to detect microbiota and metabolites through 16S rRNA gene sequencing and untargeted high-performance liquid chromatography with mass spectrometry. Results: The composition of the LRT microbial communities and metabolites differed in disease states. CAP patients showed a significantly low abundance and both diseases presented a depletion of some genera of the phylum Bacteroidetes, including Prevotella, Porphyromonas , and health-associated metabolites, such as sphingosine (d16:1), which were negatively correlated with infectious indicators. In contrast, Bacillus and Mycoplasma were both enriched in the disease groups. Streptococcus was specifically increased in CTD-ILD. In addition, co-elevated metabolites such as FA (22:4) and pyruvic acid represented hypoxia and inflammation in the diseases. Significantly increased levels of amino acids and succinate, as well as decreased itaconic acid levels, were observed in CAP patients, whereas CTD-ILD patients showed only a handful of specific metabolic alterations. Functions related to microbial lipid and amino acid metabolism were significantly altered, indicating the possible contributions of microbial metabolism. Dual omics analysis showed a moderate positive correlation between the microbiome and metabolome. The levels of L-isoleucine and L-arginine were negatively correlated with Streptococcus , and itaconic acid positively correlated with Streptococcus. Conclusion: In the LRT microenvironment, shared and specific alterations occurred in CAP and CTD-ILD patients, which were associated with inflammatory and immune reactions, which may provide a new direction for future studies aiming to elucidate the mechanism, improve the diagnosis, and develop therapies for different respiratory diseases. Keywords: community-acquired pneumonia, connective tissue disease-associated interstitial disease, microbiome, metabolome, shared and specific alterations Community-acquired pneumonia (CAP) and connective tissue disease-associated interstitial disease (CTD-ILD) are dynamic, heterogeneous, debilitating lung diseases with multiple comorbidities that affect millions of people worldwide. 1,2 In particular, CAP is acquired outside of a health care setting, and characterized by alveolar infection and intense acute inflammatory responses. 3–6 CTD-ILD is a group of respiratory disorders characterized by dyspnea, and/or impaired pulmonary function, 7 and radiological and histopathological evaluation of the lungs shows patterns of chronic inflammation and fibrosis. 8 These pathophysiological disorders alter lung physiology and could be associated with lung microenvironment dysbiosis. Human microbial communities are typically complex and involve interactions between immune functions and metabolic pathways to eradicate infection while prev -Abstract Truncated-
immunology